Skip to main content
Clinical Trials/JPRN-UMIN000045732
JPRN-UMIN000045732
Completed
未知

Effects of consumption of the proanthocianidins derived from Acacia Bark on blood pressure: a randomized, double-blind, placebo-controlled, parallel-group trial - Effects of consumption of the test food on blood pressure

ORTHOMEDICO Inc.0 sites44 target enrollmentOctober 12, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy Japanese subjects
Sponsor
ORTHOMEDICO Inc.
Enrollment
44
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 12, 2021
End Date
March 5, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2\. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3\. Subjects who currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4\. Subjects who take "Foods for Specified Health Uses," "Foods with Functional Claims," or other functional food/beverage in daily use 5\. Subjects who currently taking medications (including herbal medicines) and supplements 6\. Subjects who are allergic to medicines and/or the test food related products 7\. Subjects who suffer from coronavirus disease 2019 (COVID\-19\) 8\. Subjects who are smokers 9\. Subjects who are pregnant, lactation, or planning to become pregnant 10\. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 11\. Subjects who are judged as ineligible to participate in the study by the physician

Outcomes

Primary Outcomes

Not specified

Similar Trials